TR199701728T1 - Sialil-Lewis X ve sialil-Lewis A taklitleri olarak digikosilatlanm�� 1,-2-dioller. - Google Patents

Sialil-Lewis X ve sialil-Lewis A taklitleri olarak digikosilatlanm�� 1,-2-dioller.

Info

Publication number
TR199701728T1
TR199701728T1 TR97/01728T TR9701728T TR199701728T1 TR 199701728 T1 TR199701728 T1 TR 199701728T1 TR 97/01728 T TR97/01728 T TR 97/01728T TR 9701728 T TR9701728 T TR 9701728T TR 199701728 T1 TR199701728 T1 TR 199701728T1
Authority
TR
Turkey
Prior art keywords
lewis
sialyl
mimics
digicosylated
diols
Prior art date
Application number
TR97/01728T
Other languages
English (en)
Turkish (tr)
Inventor
Christian Kolb Hartmuth
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of TR199701728T1 publication Critical patent/TR199701728T1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/207—Cyclohexane rings not substituted by nitrogen atoms, e.g. kasugamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/02—Heterocyclic radicals containing only nitrogen as ring hetero atoms
TR97/01728T 1995-06-29 1996-06-26 Sialil-Lewis X ve sialil-Lewis A taklitleri olarak digikosilatlanm�� 1,-2-dioller. TR199701728T1 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH191495 1995-06-29

Publications (1)

Publication Number Publication Date
TR199701728T1 true TR199701728T1 (xx) 1998-03-21

Family

ID=4221546

Family Applications (1)

Application Number Title Priority Date Filing Date
TR97/01728T TR199701728T1 (xx) 1995-06-29 1996-06-26 Sialil-Lewis X ve sialil-Lewis A taklitleri olarak digikosilatlanm�� 1,-2-dioller.

Country Status (19)

Country Link
EP (1) EP0836610A1 (ru)
JP (1) JPH11508548A (ru)
KR (1) KR19990028543A (ru)
CN (1) CN1196731A (ru)
AU (1) AU707474B2 (ru)
BR (1) BR9609285A (ru)
CA (1) CA2224346A1 (ru)
CZ (1) CZ419797A3 (ru)
EA (1) EA001356B1 (ru)
HU (1) HUP9801805A3 (ru)
IL (1) IL118740A0 (ru)
MX (1) MX9800218A (ru)
NO (1) NO976065L (ru)
NZ (1) NZ311686A (ru)
PL (1) PL324258A1 (ru)
SI (1) SI9620099A (ru)
SK (1) SK177897A3 (ru)
TR (1) TR199701728T1 (ru)
WO (1) WO1997001569A1 (ru)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002036587A2 (en) 2000-11-01 2002-05-10 Cor Therapeutics, Inc. Process for the production of 4-quinazolinylpiperazin-1-carboxylic acid phenylamides
EP1577289A1 (en) * 2004-03-18 2005-09-21 Revotar Biopharmaceuticals AG Non-glycosylated/-glycosidic/-peptidic small molecule selectin inhibitors for the treament of inflammatory disorders
JP5209476B2 (ja) 2005-09-02 2013-06-12 グリコミメティクス， インコーポレイテッド ヘテロ二官能性全セレクチン阻害剤
EP1764093A1 (en) 2005-09-20 2007-03-21 Revotar Biopharmaceuticals AG Novel aromatic compounds and their use in medical applications
EP1764096A1 (en) 2005-09-20 2007-03-21 Revotar Biopharmaceuticals AG Novel phloroglucinol derivatives having selectin ligand activity
EP1764095A1 (en) 2005-09-20 2007-03-21 Revotar Biopharmaceuticals AG Novel nitrocatechol derivatives having selectin ligand activity
JP5298020B2 (ja) * 2006-10-12 2013-09-25 グリコミメティクス， インコーポレイテッド ヘキソースおよびｎ−アセチルヘキソサミンの糖模倣体置換
NZ598863A (en) * 2007-02-09 2013-11-29 Glycomimetics Inc Methods of use of glycomimetics with replacements for hexoses and n-acetyl hexosamines
US8895510B2 (en) 2008-04-08 2014-11-25 Glycomimetics, Inc. Pan-selectin inhibitor with enhanced pharmacokinetic activity
US8921328B2 (en) 2010-09-14 2014-12-30 Glycomimetics, Inc. E-selectin antagonists
ES2655443T7 (es) 2011-12-22 2021-03-22 Glycomimetics Inc Compuestos antagonistas de E-selectina
CA2891514C (en) 2012-12-07 2020-08-25 Glycomimetics, Inc. Compounds, compositions and methods using e-selectin antagonists for mobilization of hematopoietic cells
CN107108679B (zh) 2014-12-03 2020-10-23 糖模拟物有限公司 E-选择蛋白和cxcr4趋化因子受体的异双官能抑制剂
CA3009836A1 (en) 2016-01-22 2017-07-27 Glycomimetics, Inc. Glycomimetic inhibitors of pa-il and pa-iil lectins
WO2017151708A1 (en) 2016-03-02 2017-09-08 Glycomimetics, Inc. Methods for the treatment and/or prevention of cardiovescular disease by inhibition of e-selectin
US11433086B2 (en) 2016-08-08 2022-09-06 Glycomimetics, Inc. Combination of T-cell checkpoint inhibitors with inhibitors of e-selectin or CXCR4, or with heterobifunctional inhibitors of both E-selectin and CXCR4
JP7069136B2 (ja) 2016-10-07 2022-05-17 グリコミメティクス， インコーポレイテッド 極めて強力な多量体ｅ－セレクチンアンタゴニスト
JP7272956B2 (ja) 2017-03-15 2023-05-12 グリコミメティクス， インコーポレイテッド Ｅ－セレクチンアンタゴニストとしてのガラクトピラノシル－シクロヘキシル誘導体
US11712446B2 (en) 2017-11-30 2023-08-01 Glycomimetics, Inc. Methods of mobilizing marrow infiltrating lymphocytes and uses thereof
CN111566117A (zh) 2017-12-29 2020-08-21 糖模拟物有限公司 E-选择蛋白和半乳凝素-3的异双功能抑制剂
AU2019230013A1 (en) 2018-03-05 2020-09-10 Glycomimetics, Inc. Methods for treating acute myeloid leukemia and related conditions
US11845771B2 (en) 2018-12-27 2023-12-19 Glycomimetics, Inc. Heterobifunctional inhibitors of E-selectin and galectin-3

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5326752A (en) * 1991-11-27 1994-07-05 Glycomed Incorporated Substituted lactose and lactosamine derivatives as cell adhesion inhibitors
WO1993023031A1 (en) * 1992-05-08 1993-11-25 The Biomembrane Institute Multivalent mimetics and peptide mimetics for blocking carbohydrate-dependent cellular interaction and for eliciting anticarbohydrate t-cell response
CA2100412A1 (en) * 1992-07-15 1994-01-16 Yutaka Yamada Glycolipid derivatives

Also Published As

Publication number Publication date
SK177897A3 (en) 1998-08-05
NO976065D0 (no) 1997-12-23
WO1997001569A1 (en) 1997-01-16
AU707474B2 (en) 1999-07-08
AU6305396A (en) 1997-01-30
EA001356B1 (ru) 2001-02-26
BR9609285A (pt) 1999-05-11
EP0836610A1 (en) 1998-04-22
HUP9801805A3 (en) 2002-01-28
HUP9801805A2 (hu) 1998-12-28
SI9620099A (sl) 1998-08-31
CZ419797A3 (cs) 1998-06-17
NZ311686A (en) 2000-01-28
NO976065L (no) 1998-02-17
MX9800218A (es) 1998-07-31
JPH11508548A (ja) 1999-07-27
KR19990028543A (ko) 1999-04-15
EA199800103A1 (ru) 1998-08-27
PL324258A1 (en) 1998-05-11
CA2224346A1 (en) 1997-01-16
IL118740A0 (en) 1996-10-16
CN1196731A (zh) 1998-10-21

Similar Documents

Publication Publication Date Title
TR199701728T1 (xx) Sialil-Lewis X ve sialil-Lewis A taklitleri olarak digikosilatlanm�� 1,-2-dioller.
DE69133299D1 (de) Aminosulfonylcarbamate
SE7908727L (sv) Fosfinylalkanoylproliner
EA199800141A1 (ru) Гетероциклические соединения
ES2032229T3 (es) Inhibidores de proteasas benzamidicos.
KR890002198A (ko) 유기 규소 화합물
SE8704599D0 (sv) Teobrominderivat
DE69834508D1 (de) Aptoptoseinhibitoren
TR199901943T2 (xx) Akrilonitril bile�ikleri, bunlar� �retmek i�in i�lem ve bunlar� i�eren pestisitler.
EA200100310A1 (ru) Кислородсодержащие гетероциклические соединения
TR199903277T2 (xx) Benzimidazol t�revleri.
FI952101A (fi) Merkaptopyrrolidin-2-tioni
AR247744A1 (es) Compuestos organosilano y catalizadores que contienen dichos compuestos
TW427979B (en) A condensed piperidine compound
KR860700250A (ko) 신규 아미딘 화합물
SE8503415D0 (sv) Novel isoindolinyl-alkyl-piperazines
DE3860300D1 (de) Tieftemperaturschmieroel.
GB1531946A (en) Cyclopentane derivatives useful as perfuming agents
TW350041B (en) Bis-depside tertiary alkyl ester derivatives and chemical positive photoresist material
ES2005192A6 (es) Procedimiento para la fabricacion de un derivado de 1,5-diofenil-ih-1,2,4-triazol-3-carboxamida.
ATE26268T1 (de) 2-alkoxyaminosulfonylbenzolsulfonyl-harnstoffderivate.
MX9303976A (es) Derivados de 2-amino-n-{{((4-(aminocarbonil)-pirimidin-2-il-amino)-alquil}-pirimidi n-4-carboxamida, su preparacion y su aplicacion en terapeutica.
IS4556A (is) 17-díflúorómteýlen-östratríen
TR199701289T2 (xx) Karbapenemlerin esterleri
KR890004708A (ko) 위장관의 운동기능 조절제